State Bank of Pakistan

Rokt, founded in 2012 and headquartered in New York City, is a global leader in ecommerce technology. The company's mission is to unlock real-time relevancy in ecommerce transactions, enhancing customer engagement and driving incremental value for its clients. ## Technology and Products Rokt leverages AI and machine learning through its platform, Rokt Brain, to optimize customer interactions. Key products and services include: - Rokt Network: A multi-sided marketplace for partners, advertisers, and customers. - AfterSell: Boosts engagement and increases average order value through checkout and post-purchase upsells. - Rokt Pay+: Turns payment moments into revenue-generating opportunities. - Rokt Thanks: Enhances customer lifetime value in the post-purchase journey. - Rokt Ads: A performance marketing channel for customer acquisition. - mParticle: An end-to-end customer data platform integrating Rokt Brain with actionable analytics. ## Client Base and Reach Rokt powers over 6.5 billion transactions annually, connecting 400 million customers across 15 countries in North America, Europe, and Asia-Pacific. Notable clients include Live Nation, AMC Theatres, PayPal, Uber, Hulu, Staples, Albertsons, and HelloFresh. ## Growth and Recognition The company has achieved consistent annual growth of over 40% for the past decade. Rokt has been recognized as one of the fastest-growing private companies in the US by Inc. for three consecutive years and has received awards such as the MarTech Breakthrough Award. ## Work Culture and Offices Rokt maintains a mission-driven, hyper-growth culture emphasizing teamwork and innovation. The company has offices in 9 global locations, including New York, London, Seattle, Sydney, and Tokyo. Employees typically work from physical offices four days a week, with quarterly flexibility for remote work. ## Data Security and Integration Rokt ensures robust data security by storing data on Amazon Web Services (AWS) with encryption-at-rest using AES-256 and additional encryption for personally identifiable information. The company integrates various data types to deliver personalized customer experiences while maintaining strict confidentiality and security protocols.

Polymarket is a decentralized prediction market platform built on the Ethereum blockchain, allowing users to speculate on real-world event outcomes. Key features include: 1. Decentralization and Transparency: Utilizes smart contracts for trustless, transparent transactions. 2. Market Creation: Users create markets on various topics, phrasing them as yes/no questions. 3. Trading Mechanism: Users buy shares in possible outcomes, with prices reflecting perceived probabilities. 4. Liquidity Pools: Automated market maker-like system ensures constant liquidity. 5. Outcome Resolution: Independent oracles verify event outcomes and settle markets. 6. Revenue Model: - Trade fees - $20 market creation fee - Data monetization through selling anonymized insights 7. User Experience: Accessible interface, USDC-based transactions, and multiple wallet options. 8. Technical Framework: - Conditional Token Framework (CTF) for prediction management - Central Limit Order Book (CLOB) for order processing - UMA protocol for decentralized oracle and dispute resolution Polymarket offers a unique platform for event prediction and profit potential while providing valuable public sentiment insights.

Insilico Medicine is a pioneering biotechnology company leveraging artificial intelligence (AI), genomics, big data analysis, and deep learning to revolutionize drug discovery and development. Founded in 2014 by Alex Zhavoronkov, the company is headquartered in Boston, Massachusetts, with additional facilities in Hong Kong and New York. Insilico Medicine's AI-driven approach utilizes advanced technologies such as generative adversarial networks (GANs) and reinforcement learning to analyze compound effects on cells and design novel molecular structures. This innovative method significantly reduces drug development costs and time, potentially shortening the process from 4-6 years to just 2 years. The company has developed several AI-empowered platforms: - PandaOmics: For genomic and transcriptomic analysis - Chemistry42: For chemical synthesis and compound design - inClinico: For clinical trial design and management Insilico Medicine focuses on various therapeutic areas, including cancer, fibrosis, immunology, central nervous system diseases, and aging-related conditions. The company aims to identify novel drug targets and develop dual-purpose therapeutics that address specific diseases while also targeting aging. Collaborations and partnerships play a crucial role in Insilico Medicine's success. The company has established strong relationships with major pharmaceutical companies such as Taisho Pharmaceutical, Astellas, Boehringer Ingelheim, Pfizer, and Fosun Pharma. Additionally, it collaborates with academic institutions like the University of Toronto, University of Chicago, and Harvard Medical School. Since its inception, Insilico Medicine has raised over $424 million in funding, with notable rounds including a $37 million Series B in 2019, a $255 million Series C in 2021, and a $60 million Series D in 2022. The company has filed over 300 patents and published more than 200 peer-reviewed papers. Insilico Medicine's pipeline includes 31 programs targeting 29 drug targets across various disease areas, with four programs currently in clinical trials. The company's lead fibrosis drug has advanced to Phase II trials. Operating on a flexible business model, Insilico Medicine provides machine learning services through its Pharma.AI division while also developing its own therapeutics. This approach allows the company to innovate and streamline the drug development process using its AI platforms.

Ayar Labs is a pioneering company in the field of optical interconnect solutions, addressing data bottlenecks in high-performance computing (HPC), artificial intelligence (AI), and datacenter operations. Here are the key aspects of their innovative work: ### Optical I/O Technology Ayar Labs has developed the industry's first in-package optical I/O, enabling direct optical communications between critical components in HPC and AI systems. This groundbreaking technology significantly enhances data transfer efficiency and speed. ### Silicon-Based Photonic Transceivers The company is creating new intra-rack configurations using silicon-based photonic transceivers. These optical devices, which transmit and receive information, are integrated with electronic processor chips to reduce size, cost, and energy consumption. ### Integrated Packaging Ayar Labs' approach involves packaging photonic transceivers with electronic processor chips, bringing photonics closer to the chip. This integration increases energy efficiency by reducing the number of 'hops' between components and alleviates chip interconnect bottlenecks. ### Potential Impact The successful deployment of Ayar Labs' technology is expected to significantly improve datacenter energy efficiency, potentially doubling it over the next decade. This can lead to reduced energy-related emissions, lower operating costs for datacenters, and enhanced economic competitiveness. ### Applications Their optical I/O solutions are tailored for large-scale AI workloads, HPC systems, and other data-intensive applications such as 'big data' analytics and machine learning. Industry leaders like HPE, Intel, Lockheed, and NVIDIA are exploring these technologies to revolutionize data movement across various sectors. ### Environmental and Economic Benefits By reducing overall energy consumption in datacenters, Ayar Labs' solutions contribute to lower energy-related emissions. Additionally, the cost savings from more efficient operations can improve economic competitiveness in the rapidly evolving field of data processing and storage.